FDA Inspection 1192943 — BioLife Plasma Services LP
The FDA completed an inspection of BioLife Plasma Services LP on Dec 7, 2022 in Joplin, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 7, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Joplin, MO (United States)